MY108437A - Imidazopyridine paf/h1 antagonists - Google Patents

Imidazopyridine paf/h1 antagonists

Info

Publication number
MY108437A
MY108437A MYPI92000223A MYPI19920223A MY108437A MY 108437 A MY108437 A MY 108437A MY PI92000223 A MYPI92000223 A MY PI92000223A MY PI19920223 A MYPI19920223 A MY PI19920223A MY 108437 A MY108437 A MY 108437A
Authority
MY
Malaysia
Prior art keywords
paf
antagonists
imidazopyridine
formula
ring
Prior art date
Application number
MYPI92000223A
Other languages
English (en)
Inventor
Robert John Dr Bass
David Dr Alker
Kelvin Dr Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY108437A publication Critical patent/MY108437A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
MYPI92000223A 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists MY108437A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
MY108437A true MY108437A (en) 1996-09-30

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92000223A MY108437A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists

Country Status (29)

Country Link
US (1) US5358953A (OSRAM)
EP (1) EP0572425B1 (OSRAM)
JP (1) JP2506541B2 (OSRAM)
KR (1) KR970005302B1 (OSRAM)
CN (1) CN1040326C (OSRAM)
AT (1) ATE109482T1 (OSRAM)
AU (1) AU650322B2 (OSRAM)
BR (1) BR9205615A (OSRAM)
CA (1) CA2099381C (OSRAM)
CZ (1) CZ280504B6 (OSRAM)
DE (1) DE69200304T2 (OSRAM)
DK (1) DK0572425T3 (OSRAM)
EG (1) EG20085A (OSRAM)
ES (1) ES2059212T3 (OSRAM)
FI (1) FI933531A7 (OSRAM)
GB (1) GB9102997D0 (OSRAM)
HU (2) HUT65947A (OSRAM)
IE (1) IE65125B1 (OSRAM)
IL (1) IL100887A (OSRAM)
MX (1) MX9200589A (OSRAM)
MY (1) MY108437A (OSRAM)
NO (1) NO300592B1 (OSRAM)
NZ (1) NZ241597A (OSRAM)
PL (1) PL169304B1 (OSRAM)
RU (1) RU2114845C1 (OSRAM)
TW (1) TW227000B (OSRAM)
WO (1) WO1992014734A1 (OSRAM)
YU (1) YU48238B (OSRAM)
ZA (1) ZA921005B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US5753671A (en) * 1994-08-10 1998-05-19 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (H1) and platelet activating factor (PAF) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
MX9707187A (es) * 1995-08-05 1997-11-29 British Biotech Pharm Derivados de imidazopiridina.
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
ES2572454T3 (es) 2003-05-15 2016-05-31 Ampio Pharmaceuticals Inc Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
CA2713293A1 (en) 2008-01-30 2009-08-06 Nippon Zoki Pharmaceutical Co., Ltd. Piperidine derivative
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
CN103619839B (zh) * 2011-06-28 2016-06-01 福建省闽东力捷迅药业有限公司 抗-变态反应的苯并环庚并噻吩衍生物
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
AU2012323320B2 (en) 2011-10-10 2017-05-11 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2771007B1 (en) * 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
MX2015010937A (es) 2013-03-15 2015-10-29 Ampio Pharmaceuticals Inc Composiciones para la movilizacion, autodireccion, expansion y diferenciacion de celulas madre y metodos para usar las mismas.
WO2016028790A1 (en) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (OSRAM) * 1963-04-24
EP0404797B1 (en) * 1988-03-15 1995-02-01 G.D. Searle & Co. 1H/3H-[4-(N,N-CYCLOALKYL AND/OR BRANCHED-ALKYLCARBOXAMIDO) -BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
CA1341370C (en) * 1988-04-28 2002-06-18 John J. Powinski Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
ATE112567T1 (de) * 1990-05-09 1994-10-15 Pfizer Imidazo(4,5-c>pyridine als paf antagonisten.

Also Published As

Publication number Publication date
PL169304B1 (pl) 1996-06-28
ATE109482T1 (de) 1994-08-15
JPH06504992A (ja) 1994-06-09
EG20085A (en) 1997-05-31
FI933531A0 (fi) 1993-08-10
GB9102997D0 (en) 1991-03-27
DE69200304D1 (de) 1994-09-08
AU650322B2 (en) 1994-06-16
IL100887A (en) 1996-01-19
KR970005302B1 (ko) 1997-04-15
YU48238B (sh) 1997-08-22
NO300592B1 (no) 1997-06-23
AU1168392A (en) 1992-09-15
WO1992014734A1 (en) 1992-09-03
NO932889D0 (no) 1993-08-13
FI933531L (fi) 1993-08-10
DE69200304T2 (de) 1994-12-08
IE920449A1 (en) 1992-08-12
NZ241597A (en) 1993-04-28
MX9200589A (es) 1992-10-01
HU9302327D0 (en) 1993-10-28
EP0572425B1 (en) 1994-08-03
US5358953A (en) 1994-10-25
HU211202A9 (en) 1995-11-28
FI933531A7 (fi) 1993-08-10
TW227000B (OSRAM) 1994-07-21
HUT65947A (en) 1994-08-29
YU14392A (sh) 1994-11-15
CN1040326C (zh) 1998-10-21
IL100887A0 (en) 1992-11-15
RU2114845C1 (ru) 1998-07-10
BR9205615A (pt) 1994-05-17
JP2506541B2 (ja) 1996-06-12
CA2099381A1 (en) 1992-08-14
CZ280504B6 (cs) 1996-02-14
EP0572425A1 (en) 1993-12-08
NO932889L (no) 1993-08-13
DK0572425T3 (da) 1994-09-12
CA2099381C (en) 1996-07-09
ZA921005B (en) 1993-08-12
CN1064275A (zh) 1992-09-09
CS42592A3 (en) 1992-09-16
IE65125B1 (en) 1995-10-04
ES2059212T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
MY108437A (en) Imidazopyridine paf/h1 antagonists
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
YU82304A (sh) Kristalni 3,4,4-trisupstituisani-piperidinil-n-alkilkarboksilati, intermedijeri i postupak za dobijanje
HU9503930D0 (en) Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
ES2062064T3 (es) Derivados de (hidroxi-1 piperidinil-2 alquil)indolonas-2, quinoleinas-2, benzo(b)acepinonas-2, bencimidaizonas-2 y quinazolinonas-2, su preparacion y su aplicacion en terapeutica.
IL69912A (en) Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents
GR3005072T3 (OSRAM)
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
DE3269272D1 (en) Organopolysiloxanes and their use as anti-foaming agents in aqueous dispersions and solutions of synthetic resins
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
YU46589B (sh) Smeše kaučuka koje se mogu vulkanizovati
JPS5430184A (en) 3,4-dihydrocarbostyril derivative
EP0134112A3 (en) Pharmaceutical composition for prophylaxis or treatment of ketosis in livestock
TW225989B (OSRAM)
PH30229A (en) Pyridyl substituted benzothiazole compounds which has useful pharmaceutical utility
ES2062568T3 (es) Nuevos derivados de benzo (b) fenantrolinas-1,7 su preparacion y su aplicacion en terapeutica.
IL62226A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
JPS5424882A (en) Novel heterocyclic compounds and their preparation
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
MY103521A (en) Bicyclocatechol derivatives
DE3465995D1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
IL67564A (en) 7-heteroaryl-(1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them
DE69001794D1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
GB1036395A (en) New condensed heterocyclic compounds, their preparation and use